AUROPHARMA vs CIPLA vs LUPIN vs MAXHEALTH: which stock is better?
Aurobindo Pharma Limited (AUROPHARMA) has the highest StockLens rating in this group at 8.1/10 (Excellent).
| Metric | AUROPHARMA | CIPLA | LUPIN | MAXHEALTH |
|---|---|---|---|---|
| Overall rating | 8.1/10 (Excellent) | 5.0/10 (Average) | 6.1/10 (Average) | 5.0/10 (Average) |
| Long-term view | Strong long-term candidate | Neutral (watchlist) | Good for long-term | Neutral (watchlist) |
| Trade bias | Strong long | Long bias | Strong short | No clear edge |
| Share price | ₹1,796.30 | ₹1,417.00 | ₹1,971.90 | ₹1,022.85 |
| Market cap | ₹1,03,355 Cr | ₹1,14,478 Cr | ₹90,174 Cr | ₹99,557 Cr |
| P/E | 26.0 | 39.5 | 17.4 | 72.4 |
| Return on equity | 10.7% | 8.3% | 23.9% | 12.8% |
| Debt / equity | 0.22 | 0.02 | 0.26 | 0.33 |
| Revenue growth (YoY) | +23.9% | -1.1% | +11.1% | +20.3% |
| 1-year return | +55.6% | -6.5% | -0.2% | -6.6% |
Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.